You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection
Insights

Designing The Cell Therapy Facility Of The Future

Feb 06, 2017

Insights

Designing The Cell Therapy Facility Of The Future

Feb 06, 2017

In 1931, Swiss doctor Paul Niehans injected a preparation of live cells from a parathyroid gland into a dying patient. The patient subsequently recovered, and Dr. Niehans had a eureka moment — that injections of living cells can have tremendous therapeutic value.

 

Today, there are 13 FDA-approved cellular therapies on the market and over 10,000 clinical trials open for cell therapies. (By comparison, there are approximately 3,000 trials are open for antibodies.) Additionally, the FDA just this month created the new Regenerative Advanced Therapy designation to expedite the development and review of cell therapies for serious or life-threatening conditions. The small number of approved products, large number of trials, and favorable regulatory climate raise the odds of a large gap in manufacturing capacity occurring in the not-so-distant future.

To read more go to https://www.bioprocessonline.com/doc/designing-the-cell-therapy-facility-of-the-future-0001

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue